BUSINESSTHE RIO TIMES
Brazil’s Cancer Giant Has $24m in Cash and $680m Due This Year
The company held $24m in cash against $680m in short-term financial obligations as of March 31. Financial creditors are being asked to accept a 40-50% write-off on $640m of debt, while $84m of company cash was trapped in deposits.
Mentioned
Related Signal
Adjacent reporting
- Nissan's annual debt payments hit $690m, slowing turnaround
- Aave says creditors are trying to seize stolen ETH before victims get their $71M back
- Braskem Asks Creditors for Time as the Chemical Giant Fights On
- Nakamoto Inc. (NAKA) Strengthens Balance With 600 Bitcoin Sale, Refinancing, and Buyback Authorization
- Is MEXC on the verge of liquidation?